WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 2:58 pm Sale | 2022-12-30 | 13G | Verve Therapeutics, Inc. VERV | WELLINGTON MANAGEMENT GROUP LLP | 859,102 1.390% | -3,080,406 (-78.19%) | Filing |
| 2022-02-04 09:24 am Purchase | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | WELLINGTON MANAGEMENT GROUP LLP | 3,939,508 8.180% | 3,939,508 (New Position) | Filing |